Pay in 4 interest-free payments of $43.75 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
BAY11-7082
which can be significantly enhanced when combined with radiation
compound list : BAY-87-2243
(+)-JQ1 potently decreases expression of both BRD4 target genes
8(11):2992-3000
TAK-875 (Fasiglifam) - GPR40 Agonist. CAS# 1374598-80-7 0083 BAY11-7082TAK 875 (Fasiglifam), CAS No. 1374598 80 7, is the potent, selective and orally bioavailable partial GPR40 agonist with an EC50 ~14 nM. It has binding affinity to the human GPR40 receptor with Ki of 38 nM and the rat GPR40 receptor with Ki of 140 nM. TAK 875 has no agonist potency to other members of the FFA receptor family with EC50 >10 M. The 2. 3 resolution co complex structure of hGPR40 TAK 875 reveals a unique binding mode of TAK 875 and suggests
US$ 155.00
US$ 157.50
US$ 591.50
US$ 150.00
US$ 178.00
US$ 254.50
US$ 263.00
US$ 116.50
US$ 114.00
US$ 611.00